on VALBIOTIS (EPA:ALVAL)
Valbiotis: Results of the General Meeting of April 18, 2025
On April 18, 2025, Valbiotis held its Combined General Meeting in La Rochelle. Chaired by Sébastien Peltier, co-founder and Chairman of the Executive Board, this meeting saw the adoption of the majority of the proposed resolutions. However, resolutions 9 to 12 were not adopted.
Sébastien Peltier expressed his gratitude to shareholders for their support. The company aims to become a leader in the field of natural health supplements. Targets for early 2025 appear to be on track, reinforcing confidence in Valbiotis's development plan.
For more information on this General Meeting, Valbiotis has made details available via their website.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news